spinoffs

Diversionary Therapy Technologies Pty Ltd (DTT) was established as a joint venture between the Australasian Cooperative Research Centre for Interaction Design (ACID) and local investors to commercialise a new diversionary therapy device that significantly reduces pain scores during wound-dressing changes, which can be a lengthy and excruciating procedure for patients and their carers.

• Media Release: Joint venture to reduce pain for burns kids (27 November 2006)
• Read the Diversionary Therapy success story (Australian Government's Cooperative Research Centres Program Winning Ways)

ACID sold its shareholding in DTT in 2008. Since then, DTT has continued chemical trials and development, moving towards commercial release on a global scale.